C83.00
Small cell B-cell lymphoma, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Small cell B-cell lymphoma, unspecified site (ICD-10 code: C83.00), is a type of blood cancer that begins in the lymphatic system. It involves a specific form of lymphoma characterized by small, abnormal B-cells that multiply uncontrollably. Because the exact location in the body isn't specified, this diagnosis can encompass a range of presentations within the lymphatic or related tissues. Recognizing the features of this disease is important for understanding potential health implications and the general approach to diagnosis and treatment.
Causes & Symptoms
Clinical Causes: Genetic mutations that alter the normal regulation of cell growth Exposure to certain chemicals or environmental toxins Underlying immune system disorders or suppression Infections with viruses such as Epstein-Barr virus (EBV)
Key Symptoms: Swollen lymph nodes, often painless Unexplained weight loss Fever that persists or recurs Night sweats Fatigue or general weakness Loss of appetite Persistent pain or discomfort in affected areas Unexplained infections due to immune system impairment
Diagnostic & Treatment
Diagnosis Path: - Immunophenotyping tests to identify specific markers on the surface of B-cells, confirming the small cell B-cell lymphoma subtype.
Treatment Protocols: - Stem cell transplantation in select cases to replace damaged or diseased bone marrow.
Clinical Advice & FAQs
Billing Guidance
Is C83.00 a billable ICD-10 code?
Yes, C83.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.00?
Clinical documentation must specify the nature of Small cell B-cell lymphoma, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference